Product
Oral decitabine/Cedazuridine
1 clinical trial
7 indications
Indication
Myelodysplastic SyndromesIndication
LeukemiaIndication
myeloidIndication
AcuteIndication
MyelomonocyticIndication
ChronicIndication
Patient PreferenceClinical trial
A Phase 3b, Randomized, Open-Label, Double Crossover Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Adult Patients With IPSS R Intermediate Myelodysplastic Syndrome, Low Blast Acute Myeloid Leukemia, IPSS Intermediate-2 or High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaStatus: Recruiting, Estimated PCD: 2025-04-01